Thus, our results suggest that deletion of Nf2 may specifically release tumor-promoting mechanisms that are independent of CD44; or alternatively, CD44 function is compensated by other molecules in Cd44-deficient Nf2-mutant mice. The gene discussed is CD44; the disease is neoplasm.